Dendritic cells transplanted into patients for cancer immunotherapy can be tracked by MRI.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Schuler, G. et al. Curr Opin. Immunol. 15, 138–147 (2003)
de Vries, I.J. et al. Nat. Biotechnol. 23, 1407–1413 (2005).
Steinman, R.M. Annu. Rev. Immunol. 9, 271–296 (1991).
Bonifaz, L.C. et al. J. Exp. Med. 199, 815–824 (2004).
Tacken, P.J. et al. Blood 106, 1278–1285 (2005).
Bousso, P. & Robey E. Nat. Immunol. 4, 579–585 (2003).
de Vries, I.J. et al. Cancer Res. 63, 12–17 (2003).
Adema, G.J. et al. Curr. Opin. Immunol. 17, 170–174 (2005).
Garg, S. et al. Nat. Immunol. 4, 907–912 (2003).
Bedrosian, I. et al. J. Clin. Oncol. 21, 3826–3835 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zitvogel, L., Tursz, T. In vivo veritas . Nat Biotechnol 23, 1372–1374 (2005). https://doi.org/10.1038/nbt1105-1372
Issue Date:
DOI: https://doi.org/10.1038/nbt1105-1372